267 related articles for article (PubMed ID: 27100708)
41. Exosome-based regenerative rehabilitation: A novel ice breaker for neurological disorders.
Wang YY; Cheng J; Liu YD; Wang YP; Yang QW; Zhou N
Biomed Pharmacother; 2023 Dec; 169():115920. PubMed ID: 37995565
[TBL] [Abstract][Full Text] [Related]
42. Exosomes and cardiovascular cell-cell communication.
Poe AJ; Knowlton AA
Essays Biochem; 2018 May; 62(2):193-204. PubMed ID: 29717058
[TBL] [Abstract][Full Text] [Related]
43. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology.
Gray WD; French KM; Ghosh-Choudhary S; Maxwell JT; Brown ME; Platt MO; Searles CD; Davis ME
Circ Res; 2015 Jan; 116(2):255-63. PubMed ID: 25344555
[TBL] [Abstract][Full Text] [Related]
44. Characterization and Therapeutic Uses of Exosomes: A New Potential Tool in Orthopedics.
Vitha AE; Kollefrath AW; Huang CC; Garcia-Godoy F
Stem Cells Dev; 2019 Jan; 28(2):141-150. PubMed ID: 30426846
[TBL] [Abstract][Full Text] [Related]
45. Exosomes as biomimetic tools for stem cell differentiation: Applications in dental pulp tissue regeneration.
Huang CC; Narayanan R; Alapati S; Ravindran S
Biomaterials; 2016 Dec; 111():103-115. PubMed ID: 27728810
[TBL] [Abstract][Full Text] [Related]
46. Extracellular vesicles, exosomes and shedding vesicles in regenerative medicine - a new paradigm for tissue repair.
Bjørge IM; Kim SY; Mano JF; Kalionis B; Chrzanowski W
Biomater Sci; 2017 Dec; 6(1):60-78. PubMed ID: 29184934
[TBL] [Abstract][Full Text] [Related]
47. Recent advances in heart regeneration.
Xiong JW; Chang NN
Birth Defects Res C Embryo Today; 2013 Sep; 99(3):160-9. PubMed ID: 24078494
[TBL] [Abstract][Full Text] [Related]
48. The relationship between molecular content of mesenchymal stem cells derived exosomes and their potentials: Opening the way for exosomes based therapeutics.
Jafari D; Malih S; Eslami SS; Jafari R; Darzi L; Tarighi P; Samadikuchaksaraei A
Biochimie; 2019 Oct; 165():76-89. PubMed ID: 31302163
[TBL] [Abstract][Full Text] [Related]
49. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy.
Kourembanas S
Annu Rev Physiol; 2015; 77():13-27. PubMed ID: 25293529
[TBL] [Abstract][Full Text] [Related]
50. The Biological Mechanisms of Action of Cardiac Progenitor Cell Therapy.
Pagano F; Picchio V; Angelini F; Iaccarino A; Peruzzi M; Cavarretta E; Biondi-Zoccai G; Sciarretta S; De Falco E; Chimenti I; Frati G
Curr Cardiol Rep; 2018 Aug; 20(10):84. PubMed ID: 30105430
[TBL] [Abstract][Full Text] [Related]
51. Adult mesenchymal stem cells and their exosomes: Sources, characteristics, and application in regenerative medicine.
Maqsood M; Kang M; Wu X; Chen J; Teng L; Qiu L
Life Sci; 2020 Sep; 256():118002. PubMed ID: 32585248
[TBL] [Abstract][Full Text] [Related]
52. Exosomes: promising sacks for treating ischemic heart disease?
Chen GH; Xu J; Yang YJ
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H508-H523. PubMed ID: 28646026
[TBL] [Abstract][Full Text] [Related]
53. Experimental, Systems, and Computational Approaches to Understanding the MicroRNA-Mediated Reparative Potential of Cardiac Progenitor Cell-Derived Exosomes From Pediatric Patients.
Agarwal U; George A; Bhutani S; Ghosh-Choudhary S; Maxwell JT; Brown ME; Mehta Y; Platt MO; Liang Y; Sahoo S; Davis ME
Circ Res; 2017 Feb; 120(4):701-712. PubMed ID: 27872050
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic application of mesenchymal stem cell-derived exosomes: A promising cell-free therapeutic strategy in regenerative medicine.
Motavaf M; Pakravan K; Babashah S; Malekvandfard F; Masoumi M; Sadeghizadeh M
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):74-9. PubMed ID: 27453276
[TBL] [Abstract][Full Text] [Related]
55. microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential.
Qiao L; Hu S; Liu S; Zhang H; Ma H; Huang K; Li Z; Su T; Vandergriff A; Tang J; Allen T; Dinh PU; Cores J; Yin Q; Li Y; Cheng K
J Clin Invest; 2019 Apr; 129(6):2237-2250. PubMed ID: 31033484
[TBL] [Abstract][Full Text] [Related]
56. Mining Exosomal MicroRNAs from Human-Induced Pluripotent Stem Cells-Derived Cardiomyocytes for Cardiac Regeneration.
Ong SG; Lee WH; Zhou Y; Wu JC
Methods Mol Biol; 2018; 1733():127-136. PubMed ID: 29435928
[TBL] [Abstract][Full Text] [Related]
57. [Research Progress in Promotion of Tissue Regeneration and Reconstruction with Exosomes Derived from Mesenchymal Stem Cells].
Chen MY; Wang QG; Fan YJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):380-386. PubMed ID: 34018354
[TBL] [Abstract][Full Text] [Related]
58. Recent Progress Using Pluripotent Stem Cells for Cardiac Regenerative Therapy.
Ichimura H; Shiba Y
Circ J; 2017 Jun; 81(7):929-935. PubMed ID: 28603177
[TBL] [Abstract][Full Text] [Related]
59. Human Induced Pluripotent Stem Cell-Derived Exosomes as a New Therapeutic Strategy for Various Diseases.
Wang AYL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578948
[TBL] [Abstract][Full Text] [Related]
60. Exosomes and Bone Disease.
Shan SK; Lin X; Li F; Xu F; Zhong JY; Guo B; Wang Y; Zheng MH; Wu F; Yuan LQ
Curr Pharm Des; 2019; 25(42):4536-4549. PubMed ID: 31775592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
